Alibaba Health Information Technology Limited (0241.HK)
HKD 3.45
(-0.29%)
HKD 3.45
(-0.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 999.05 Million CNY | 3883.48% |
| 2022 | -24.47 Million CNY | 97.73% |
| 2021 | -188.12 Million CNY | -2164.85% |
| 2020 | 52.13 Million CNY | 198.32% |
| 2019 | -53.02 Million CNY | 43.69% |
| 2018 | -94.18 Million CNY | 30.57% |
| 2017 | -135.65 Million CNY | 31.41% |
| 2016 | -195.59 Million CNY | 7.0% |
| 2015 | -212.67 Million CNY | -46.67% |
| 2014 | -123.29 Million CNY | -1813.4% |
| 2013 | -31.17 Million CNY | -93.04% |
| 2012 | -20.09 Million CNY | -113.8% |
| 2011 | 22.1 Million CNY | 168.99% |
| 2010 | 2.74 Million CNY | 297.77% |
| 2009 | 5.91 Million CNY | 93.06% |
| 2008 | -77.08 Million CNY | -11.93% |
| 2007 | -68.86 Million CNY | -10.14% |
| 2006 | -62.52 Million CNY | -248.07% |
| 2005 | 42.22 Million CNY | 349.9% |
| 2004 | -12.15 Million CNY | -8.5% |
| 2003 | -15.57 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - CNY | 3883.48% |
| 2023 Q4 | 389.03 Million CNY | 0.0% |
| 2023 Q2 | 272.19 Million CNY | 0.0% |
| 2022 Q4 | -575 Thousand CNY | 0.0% |
| 2022 Q2 | -23.9 Million CNY | 0.0% |
| 2022 FY | - CNY | 97.73% |
| 2021 Q2 | -585.58 Million CNY | 0.0% |
| 2021 FY | - CNY | -2164.85% |
| 2021 Q4 | -490.96 Million CNY | 0.0% |
| 2020 Q4 | -175.62 Million CNY | 0.0% |
| 2020 FY | - CNY | 198.32% |
| 2020 Q2 | 227.75 Million CNY | 0.0% |
| 2019 FY | - CNY | 43.69% |
| 2019 Q2 | -5.04 Million CNY | 0.0% |
| 2019 Q4 | -47.98 Million CNY | 0.0% |
| 2018 Q2 | -61.13 Million CNY | 0.0% |
| 2018 FY | - CNY | 30.57% |
| 2018 Q4 | -33.05 Million CNY | 0.0% |
| 2017 FY | - CNY | 31.41% |
| 2017 Q2 | -96.73 Million CNY | 0.0% |
| 2017 Q4 | -38.91 Million CNY | 0.0% |
| 2016 FY | - CNY | 7.0% |
| 2016 Q2 | -104 Million CNY | 0.0% |
| 2016 Q4 | -93.78 Million CNY | 0.0% |
| 2015 Q4 | -101.66 Million CNY | 0.0% |
| 2015 Q2 | -111.01 Million CNY | 0.0% |
| 2015 FY | - CNY | -46.67% |
| 2014 FY | - CNY | -1813.4% |
| 2014 Q4 | -108.18 Million CNY | 0.0% |
| 2014 Q2 | -36.4 Million CNY | 0.0% |
| 2013 Q3 | 123.96 Thousand CNY | 100.69% |
| 2013 Q1 | -2.06 Million CNY | 79.8% |
| 2013 FY | - CNY | -93.04% |
| 2013 Q4 | -15.75 Million CNY | -12807.26% |
| 2013 Q2 | -17.99 Million CNY | -772.27% |
| 2012 Q2 | 5.52 Million CNY | 0.0% |
| 2012 FY | - CNY | -113.8% |
| 2012 Q4 | -10.21 Million CNY | -395.02% |
| 2012 Q3 | -2.06 Million CNY | -137.33% |
| 2012 Q1 | 5.52 Million CNY | 0.0% |
| 2011 Q2 | 686.58 Thousand CNY | 0.0% |
| 2011 Q3 | 5.52 Million CNY | 704.93% |
| 2011 Q4 | 5.52 Million CNY | 0.0% |
| 2011 FY | - CNY | 168.99% |
| 2011 Q1 | 686.58 Thousand CNY | 0.0% |
| 2010 Q2 | 1.47 Million CNY | 0.0% |
| 2010 FY | - CNY | 297.77% |
| 2010 Q4 | 686.58 Thousand CNY | 0.0% |
| 2010 Q1 | 1.47 Million CNY | 0.0% |
| 2010 Q3 | 686.58 Thousand CNY | -53.59% |
| 2009 Q2 | -26.28 Million CNY | 0.0% |
| 2009 FY | - CNY | 93.06% |
| 2009 Q1 | -26.28 Million CNY | 0.0% |
| 2009 Q3 | 1.47 Million CNY | 105.63% |
| 2009 Q4 | 1.47 Million CNY | 0.0% |
| 2008 Q4 | -26.28 Million CNY | 0.0% |
| 2008 Q2 | -12.8 Million CNY | 0.0% |
| 2008 Q1 | -12.8 Million CNY | 0.0% |
| 2008 FY | - CNY | -11.93% |
| 2008 Q3 | -26.28 Million CNY | -105.28% |
| 2007 Q1 | -12.34 Million CNY | 0.0% |
| 2007 Q3 | -12.8 Million CNY | -3.69% |
| 2007 Q4 | -12.8 Million CNY | 0.0% |
| 2007 Q2 | -12.34 Million CNY | 0.0% |
| 2007 FY | - CNY | -10.14% |
| 2006 Q2 | 7.76 Million CNY | 0.0% |
| 2006 Q3 | -12.34 Million CNY | -259.02% |
| 2006 Q4 | -12.34 Million CNY | 0.0% |
| 2006 FY | - CNY | -248.07% |
| 2006 Q1 | 7.76 Million CNY | 0.0% |
| 2005 Q2 | 8.13 Million CNY | 0.0% |
| 2005 FY | - CNY | 349.9% |
| 2005 Q4 | 7.76 Million CNY | 0.0% |
| 2005 Q1 | 8.13 Million CNY | 0.0% |
| 2005 Q3 | 7.76 Million CNY | -4.51% |
| 2004 Q1 | -176.3 Thousand CNY | 0.0% |
| 2004 Q3 | 8.13 Million CNY | 4712.52% |
| 2004 FY | - CNY | -8.5% |
| 2004 Q2 | -176.3 Thousand CNY | 0.0% |
| 2004 Q4 | 8.13 Million CNY | 0.0% |
| 2003 Q3 | -176.3 Thousand CNY | 0.0% |
| 2003 FY | - CNY | 0.0% |
| 2003 Q4 | -176.3 Thousand CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| China Healthwise Holdings Limited | -117.45 Million HKD | 950.61% |
| Tycoon Group Holdings Limited | 147.38 Million HKD | -577.851% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 779.54 Million HKD | -28.159% |